Skip to content
Advertisement

Danaher (DHR)USD

$233.15
Delayed

Custom

Key Statistics

Market Cap$163.94B
P/E Ratio (TTM)38.20
EPS (TTM)$6.10
Dividend Yield–
Beta (1Y)0.52
Volume3.36M
52-Week Range$160.93 – $242.80
Data provided by Twelve Data · Price by Databento

About Danaher Corporation

Danaher is a science and technology company focused on biotechnology, life sciences, and diagnostics. It works through three segments of those same names, and its revenue comes from bioprocessing tools used to make biologic medicines, instruments and consumables for research, and clinical diagnostic products. Rainer Blair serves as chief executive. Over the years Danaher has shifted from a broad industrial group toward a concentrated portfolio in health care and laboratory technology. It describes itself as a global leader across biotech, diagnostics, and life sciences.

No recent coverage for this asset.